证券代码：600682 证券简称：南京新百 公告编号：临 2023-020 本议案尚需提交至公司股东大会审议。 南京新街口百货商店股份有限公司 第十届董事会第四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 表决结果：同意 10 票，反对 0 票，弃权 0 票。 南京新街口百货商店股份有限公司（以下简称公司）第十届董事会第四次 会议（以下简称会议）于 2023 年 8 月 7 日以通讯表决的方式召开。会议通知于 2023 年 8 月 4 日以电话或邮件的方式向全体董事发出，本次会议应参会董事 10 人，实际参会董事 10 人。本次会议的通知、召开以及参与表决董事人数均符合 有关法律、法规、规则及《公司章程》的规定。会议审议并通过了如下议案： 一、审议通过了《关于补选第十届董事会非独立董事的议案》 公司董事会非独立董事、副总裁许光兴先生因个人原因向董事会辞去公司 董事及副总裁职务。根据《公司法》、《上海证券交易所股票上市规则》及《公 司章程》的相关规定和董事会提名委员会的提名及资格审查，经公司第十届董 事会第四次 ...

证券代码：600682 证券简称：南京新百 公告编号：临 2023-024 南京新街口百货商店股份有限公司 关于董事辞职及补选董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、关于董事辞职的情况 南京新街口百货商店股份有限公司(以下简称公司或本公司)董事会于近日 收到公司董事、副总裁许光兴先生递交的辞职报告，许光兴先生因个人原因，向 公司辞去公司董事及副总裁职务，辞职后许光兴先生将不再担任公司任何职务。 根据《公司法》、《上海证券交易所股票上市规则》以及《公司章程》有关规 定，许光兴先生辞职不会导致公司董事会成员人数低于法定要求，不会影响公司 及董事会的正常运作，辞职报告以送达董事会之日起生效。 许光兴先生在担任公司董事期间勤勉尽责，公司及董事会对许光兴先生在任 职期间为公司发展所做的贡献表示衷心感谢。 二、关于补选董事的情况 1 证券代码：600682 证券简称：南京新百 公告编号：临 2023-024 为保障公司董事会正常运转，公司董事会于 2023 年 8 月 7 日以通讯表决的 方式召开了第十届董事会第四 ...

证券代码：600682 证券简称：南京新百 公告编号：2023-022 南京新街口百货商店股份有限公司 关于召开 2023 年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东大会类型和届次 至 2023 年 8 月 24 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 2023 年第二次临时股东大会 召开的日期时间：2023 年 8 月 24 日 14 点 00 分 召开地点：南京市秦淮区中山南路 1 号南京中心 23 楼多功能厅 股东大会召开日期：2023年8月24日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (二) 股东大会召集人：董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 ( ...

2023 年 8 月 9 日 1 南京新街口百货商店股份有限公司独立董事 关于公司第十届董事会第四次会议 相关事项的独立意见 根据《上市公司独立董事规则》、《上市公司治理准则》等法律法规及《公司 章程》的有关规定，作为南京新街口百货商店股份有限公司（以下简称公司）的 独立董事，在认真审阅相关材料的基础上，基于独立判断立场，现就 2023 年 8 月 7 日召开的公司第十届董事会第四次会议审议的相关议案发表如下独立意见： 一、关于补选第十届董事会非独立董事的议案 公司董事会提名钱静女士为公司第十届董事会非独立董事补选候选人，该候 选人的提名程序符合《公司法》和《证券法》等法律法规及《公司章程》的规定。 我们审阅了钱静女士的个人履历等相关资料，认为钱静女士符合公司董事任职资 格，具备与其行使职权相适应的任职条件，未发现有《公司法》第 146 条规定的 情形，以及被中国证监会确定为市场禁入者，或者禁入尚未解除的情况。我们同 意提名钱静女士为公司第十届董事会董事候选人，并同意将该议案提交至公司股 东大会审议。 二、关于变更部分募集资金用途并永久补充流动资金的议案 本次将部分募投项目部分募集资金用于永久补充流动资金有利 ...

证券代码：600682 证券简称：南京新百 公告编号：临 2023-021 南京新街口百货商店股份有限公司 第九届监事会第十二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 南京新街口百货商店股份有限公司(以下简称公司) 第九届监事会第十二次 会议 (以下简称会议)于 2023 年 8 月 7 日以通讯表决的方式召开。会议通知于 2023 年 8 月 4 日以电话或邮件的方式向全体监事发出，本次会议应参会监事 3 人， 实际参会监事 3 人。本次会议的通知、召开以及参与表决监事人数均符合有关 法律、法规、规则及《公司章程》的规定。会议审议通过了《关于变更部分募 集资金用途并永久补充流动资金的议案》，该议案尚需提交至公司股东大会审 议。 监事会认为：本次将部分募投项目部分募集资金用于永久补充流动资金有利 于更好地发挥募集资金使用效益，符合公司实际经营发展需要，符合全体股东 利益，不存在损害公司股东利益的情形；本次事项涉及的审议程序符合法律、 行政法规、部门规章及其他规范性文件的规定。经监事会审议，同意本次剩余 募 ...

证券代码：600682 证券简称：南京新百 公告编号：临 2023-015 南京新街口百货商店股份有限公司 关于召开 2022 年度业绩 暨现金分红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 南京新街口百货商店股份有限公司（以下简称公司）已于 2023 年 4 月 29 日在上海证券交易所网站（www.sse.com.cn）发布公司 2022 年度报告，为便于 广大投资者更全面深入地了解公司 2022 年度经营成果、财务状况及利润分配方 案，公司计划于 2023 年 05 月 16 日下午 15:00-16:00 举行 2022 年度业绩暨现 金分红说明会，就投资者关心的问题进行交流。 证券代码：600682 证券简称：南京新百 公告编号：临 2023-015 二、 说明会召开的时间、地点 三、 参加人员 总经理：张轩先生 会议召开时间：2023 年 05 月 16 日(星期二)下午 15:00-16:00 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow ...

Financial Performance - Net profit attributable to shareholders decreased by 14.94% year-to-date compared to the previous year[5] - Net profit excluding non-recurring gains and losses decreased by 18.15% year-to-date[5] - Basic and diluted earnings per share both decreased by 18.75% year-to-date[5] - Net profit for Q1 2023 was RMB 226,501,212.08, down from RMB 251,537,370.90 in Q1 2022[14] - Comprehensive income for Q1 2023 totaled RMB 94,650,336.08, compared to RMB 194,242,281.97 in Q1 2022[14] - The basic earnings per share for Q1 2023 was ¥0.13, down 18.75% from ¥0.16 in Q1 2022[23] - The weighted average return on equity for Q1 2023 was 1.06%, a decrease of 0.17 percentage points compared to 1.23% in the same period last year[23] - The net profit attributable to shareholders of the listed company was ¥180,148,875.72, a decrease of 14.94% from ¥210,028,853.25 in the previous year[51] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥165,411,902.37, down 18.15% from ¥202,084,526.24 in the same period last year[51] Revenue and Costs - Total operating revenue for Q1 2023 was RMB 1,595,560,833.41, an increase from RMB 1,524,888,877.17 in Q1 2022[12] - The company's operating revenue for Q1 2023 was ¥1,595,560,833.41, representing a year-over-year increase of 4.63% compared to ¥1,398,864,221.81 in the same period last year[51] - Total operating costs for the period were approximately $1.33 billion, an increase from $1.23 billion in the previous period, representing an increase of about 8.3%[62] - Operating profit for the period was approximately $280.45 million, down from $306.09 million in the previous period, reflecting a decrease of about 8.4%[62] - Total profit for the period was approximately $282.94 million, compared to $305.75 million in the previous period, indicating a decline of about 7.4%[62] Cash Flow and Investments - The net cash flow from operating activities for Q1 2023 was ¥225,294,070.15, a decrease of 36.94% compared to ¥357,276,453.57 in Q1 2022[16] - Cash inflow from investment activities in Q1 2023 was ¥389,749,975.92, significantly higher than ¥84,816,766.54 in Q1 2022[17] - The net cash flow from investment activities for Q1 2023 was -¥191,781,349.33, an improvement from -¥295,796,709.76 in Q1 2022[17] - Cash inflow from financing activities in Q1 2023 was ¥137,210,000.00, compared to ¥203,214,000.00 in Q1 2022[17] - The net cash flow from financing activities for Q1 2023 was -¥38,979,528.13, an improvement from -¥130,828,417.63 in Q1 2022[17] Assets and Liabilities - Total assets at the end of Q1 2023 amounted to ¥25,420,629,239.31, reflecting a 0.81% increase from ¥25,215,359,602.91 at the end of the previous year[23] - The company's total current assets increased to ¥8,546,905,904.46 from ¥8,163,995,535.77 year-over-year[59] - The company's total liabilities increased to ¥6,062,515,585.59 from ¥5,944,696,538.91 year-over-year[60] - The company's inventory as of March 31, 2023, was ¥378,624,983.79, up from ¥287,490,302.87 in the previous year[59] - The company reported a decrease in fixed assets to ¥2,955,435,545.40 from ¥2,999,939,557.56 year-over-year[60] Expenses - Financial expenses increased by 229.78% year-to-date, primarily due to increased deposit interest[5] - Research and development expenses were approximately $57.59 million, slightly down from $59.71 million in the previous period, a decrease of about 3.6%[62] - Sales expenses decreased to approximately $129.23 million from $155.15 million, a reduction of about 16.7%[62] - Management expenses increased to approximately $296.95 million from $243.21 million, an increase of about 22.1%[62] - Financial expenses showed a significant improvement, with a net income of approximately -$11.53 million compared to a net expense of $8.88 million in the previous period[62] - Other income for the period was approximately $1.30 million, down from $2.40 million in the previous period, a decrease of about 45.8%[62] Other Information - Other comprehensive income decreased by 42.57% at the end of the reporting period, mainly due to foreign currency translation differences[5] - The company has not disclosed any significant new product developments or market expansion strategies during the reporting period[57] - The company reported investment income of approximately $5.47 million, a significant increase from $440,409.36 in the previous period[62] - The company did not report any net profit from the merged entity prior to the merger, indicating no impact on overall profitability from this activity[64]

南京新街口百货商店股份有限公司 2022 年年度报告 重要提示 三、 苏亚金诚会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 截至2022年12月31日，公司总股本1,346,132,221股，公司拟以2022年12月31日的总股本数扣 除公司回购账户的股份7,000,000股后的股份数量基数，向全体股东每10股派现金股利人民币0.2 元（含税），不送红股，也不进行资本公积转增股本，剩余未分配利润转入下一年度，以此计算 合计拟派发现金红利26,782,644.42元（含税）。在实施权益分派的股权登记日前公司有权参与 分配的股本发生变动的，维持分配总额不变，相应调整每股分配比例，并将另行公告具体调整情 况。该分配预案尚需提交公司股东大会审议通过后方能实施。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 九、 是否存在半数以上董事无法保证公司所披露年度报告的真实性、准确性和完整性 2022 年年度报告 目录 一、 释义 第二节 公司简介和主要财务指标 三、 基本情况简介 2022 年年度报告 2022 年年度报告 二、 公司全体董事出席董事会会议。 五、 董事会决议通过的本报告期 ...

Financial Performance - The company's operating revenue for Q3 2022 was ¥1,648,365,517.36, representing a 7.50% increase compared to ¥1,460,432,480.20 in the same period last year[7]. - Net profit attributable to shareholders was ¥217,845,594.15, a decrease of 20.60% from ¥267,323,324.57 year-on-year[7]. - The net profit after deducting non-recurring gains and losses was ¥219,038,224.69, down 15.10% from ¥258,005,178.04 in the previous year[7]. - The basic earnings per share for the period was ¥0.16, a decline of 20.00% compared to ¥0.20 in the same quarter last year[7]. - Net profit for the third quarter of 2022 was CNY 729,480,755.56, down from CNY 992,588,497.42 in the same quarter of 2021, representing a decline of approximately 26.5%[37]. - The net profit attributable to shareholders of the parent company for the third quarter of 2022 was CNY 613,997,506.71, compared to CNY 877,754,965.82 in the previous year, a decrease of around 30.1%[37]. - The total comprehensive income attributable to the parent company reached CNY 1,395,273,140.73, an increase from CNY 823,280,900.67 in the same period last year, reflecting a growth of approximately 69.5%[39]. Assets and Liabilities - Total assets at the end of the reporting period were ¥25,094,846,361.48, a decrease of 5.87% from ¥25,330,130,157.85 at the end of the previous year[9]. - The equity attributable to shareholders decreased by 2.53% to ¥17,103,957,965.66 from ¥17,183,697,414.14 at the end of the previous year[9]. - The company's total assets amounted to ¥25,094,846,361.48, down from ¥26,658,542,523.00, indicating a decrease of approximately 5.9%[28]. - The total liabilities decreased to ¥5,694,216,924.16 from ¥6,946,085,915.37, a reduction of about 18.1%[28]. - Total liabilities as of the reporting date were CNY 6,822,826,982.26, down from CNY 8,056,253,800.10 in the previous year, reflecting a decrease of approximately 15.3%[30]. - Total equity attributable to shareholders of the parent company was CNY 17,103,957,965.66, a slight decrease from CNY 17,548,146,059.09 in the previous year, indicating a decline of about 2.54%[30]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥953,694,148.02, down 16.20% from ¥1,115,082,509.48 in the same period last year[7]. - The company reported a significant decrease in cash and cash equivalents by 33.38% at the end of the reporting period due to changes in the scope of consolidation[15]. - The company reported cash and cash equivalents of ¥3,971,235,083.90, down from ¥5,961,390,829.95 in the previous year, representing a decrease of approximately 33.3%[25]. - The total cash inflow from operating activities amounted to CNY 6,644,652,967.26, compared to CNY 6,566,304,567.52 in the prior year, showing a slight increase of approximately 1.2%[43]. - The net cash flow from operating activities was CNY 953,694,148.02, down from CNY 1,138,064,935.49 in the previous year, indicating a decrease of about 16.2%[43]. - The cash and cash equivalents at the end of the period stood at CNY 3,965,723,253.91, down from CNY 6,213,122,754.52 in the previous year, representing a decline of about 36.1%[45]. Investments and Acquisitions - The company completed the acquisition of 100% equity in Nanjing Xinbai Real Estate Development Co., Ltd., which led to a restatement of prior period data[9]. - The company reported a net profit of CNY 6,221,820.93 from the merged entity, contrasting with a net loss of CNY -45,493,477.60 from the previous year, indicating a significant turnaround[39]. Operating Costs and Expenses - Total operating costs for the first three quarters of 2022 were CNY 3,802,240,866.18, compared to CNY 3,416,566,950.51 in 2021, indicating an increase of about 11.29%[34]. - Research and development expenses for the first three quarters of 2022 amounted to CNY 190,707,290.78, slightly up from CNY 186,195,935.06 in 2021, showing a growth of about 2.7%[34]. - The company reported a financial expense of CNY 9,465,364.00 for the third quarter of 2022, down from CNY 40,045,256.18 in the same quarter of 2021, representing a decrease of approximately 76.4%[34]. - The cash outflow for purchasing goods and services was CNY 2,544,170,156.61, up from CNY 2,262,794,669.55, reflecting an increase of about 12.4%[43]. Shareholder Information - Total number of common shareholders at the end of the reporting period was 37,100[19].

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the first half of 2022, representing a year-on-year increase of 15%[22]. - Net profit for the period was RMB 150 million, up 10% compared to the same period last year[22]. - The company’s gross margin improved to 35%, an increase of 2 percentage points from the previous year[22]. - The company's operating revenue for the first half of the year was approximately CNY 3.01 billion, a decrease of 0.40% compared to the same period last year[24]. - Net profit attributable to shareholders was approximately CNY 396.15 million, representing a decline of 34.35% year-over-year[24]. - The basic earnings per share decreased to CNY 0.29, down 35.56% from CNY 0.45 in the previous year[24]. - The company's total assets at the end of the reporting period were approximately CNY 24.37 billion, a decrease of 8.57% compared to the previous year[24]. - The net asset attributable to shareholders was approximately CNY 16.49 billion, down 6.03% from the previous year[24]. - The cash flow from operating activities was approximately CNY 679.78 million, a decrease of 4.88% compared to the same period last year[24]. - The net profit attributable to shareholders decreased by 2.07 billion yuan, a decline of 34.35% year-on-year[89]. Market Expansion and Strategy - The company plans to expand its market presence by opening 10 new stores in key cities by the end of 2022[22]. - The company has set a revenue target of RMB 2.5 billion for the full year 2022, indicating a growth forecast of 12%[22]. - The company has no plans for mergers or acquisitions in the near term, focusing instead on organic growth strategies[22]. - The company is committed to improving operational efficiency, aiming for a 5% reduction in operational costs by the end of 2022[22]. - The company is focusing on integrating technology into its services, particularly in the elderly care sector, to enhance service delivery and operational efficiency[34]. - The company is actively pursuing diversified development strategies, including R&D collaborations and investments in the life and health industry[111]. Industry Trends and Challenges - The retail sales of major retail enterprises in China decreased by 14.1% compared to the previous year, indicating a challenging market environment[33]. - The management highlighted potential risks from macroeconomic conditions and increased market competition[22]. - The company faces risks from intensified market competition, particularly from e-commerce impacting traditional retail, and plans to enhance product competitiveness and develop online business[150]. - The company is exposed to risks from potential changes in government policies affecting the elderly care sector, which could impact operations significantly[150]. - The ongoing COVID-19 pandemic poses risks to the company's operations, particularly in stem cell collection and transportation[154]. Research and Development - Investment in new product development increased by 25%, focusing on enhancing the online shopping experience[22]. - The company has invested significantly in research and development, ensuring its competitive position in the stem cell technology industry[79]. - The company is committed to expanding existing product indications and conducting clinical research on combination therapies while actively developing other cancer immunotherapies[161]. Environmental and Regulatory Compliance - The company is classified as a key pollutant discharge unit by the Shanghai Municipal Ecological Environment Bureau[178]. - The main pollutants from the company's operations include wastewater and waste gas, with specific pollutants monitored such as ammonia nitrogen and total nitrogen[178]. - The company has implemented a rainwater and sewage diversion system for wastewater management[185]. - The company has obtained a pollution discharge permit and has conducted environmental impact assessments for new projects[187]. - The company has made efforts to enhance its pollution discharge permit quality in line with the latest environmental standards[187]. Operational Efficiency and Management - The company has implemented a complete management system to track and supervise the completion of departmental work plans in real-time, ensuring operational efficiency[81]. - The company has developed a standardized service operation capability, establishing a nationwide standardized project setup system covering personnel, information, platform, system, environment, and finance[70]. - The company has established partnerships with over 20 provincial hospitals across China, enhancing its service network and collaboration in the field of stem cell technology[79]. Talent and Workforce Management - The company is addressing talent shortages in the elderly care and healthcare sectors through internal training and external recruitment strategies[155]. - The company faces risks related to talent loss, particularly in key positions, which could impact performance; it plans to establish a compensation system linked to market levels and performance to mitigate this risk[161]. Product and Service Development - Dendreon, a subsidiary of 世鼎香港, specializes in tumor immunotherapy and has developed the only FDA-approved prostate cancer immunotherapy product, PROVENGE[50]. - PROVENGE is produced using a custom order model, tailored to individual patient needs, and involves a treatment regimen of three injections[53]. - Dendreon is focusing on reinforcing Provenge's positioning as a first-line therapy for early asymptomatic or mildly symptomatic mCRPC patients[113]. - The company is preparing to submit an application to the FDA for expanding early indications for PROVENGE based on ongoing clinical trials[116].